Guangdong VTR Bio-Tech Co Ltd (300381) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong VTR Bio-Tech Co Ltd (300381) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.41 Million ≈ $8.11 Million USD) by net assets (CN¥2.64 Billion ≈ $385.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guangdong VTR Bio-Tech Co Ltd (300381) market capitalisation for the company's overall valuation and market capitalisation.
Guangdong VTR Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Guangdong VTR Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangdong VTR Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong VTR Bio-Tech Co Ltd ranked by their cash flow conversion efficiency. Explore 300381 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
J.Kumar Infraprojects Limited
NSE:JKIL
|
0.122x |
|
Samse SA
PA:SAMS
|
0.105x |
|
Guangshen Railway Company Limited
F:GRCH
|
0.026x |
|
Voxel S.A.
WAR:VOX
|
0.072x |
|
Lifestyle Communities Ltd
AU:LIC
|
0.028x |
|
Jiangsu Smartwin Electronics Technology Co.Ltd.
SHE:301106
|
N/A |
|
Mnc Land Tbk
JK:KPIG
|
0.018x |
|
Nanjing Shenghang Shipping Co Ltd
SHE:001205
|
0.034x |
Annual Cash Flow Conversion Efficiency for Guangdong VTR Bio-Tech Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Guangdong VTR Bio-Tech Co Ltd from 2007 to 2025. View Guangdong VTR Bio-Tech Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.59 Billion ≈ $379.46 Million |
CN¥121.07 Million ≈ $17.72 Million |
0.047x | +79.09% |
| 2024-12-31 | CN¥2.65 Billion ≈ $388.39 Million |
CN¥69.19 Million ≈ $10.13 Million |
0.026x | -53.82% |
| 2023-12-31 | CN¥2.74 Billion ≈ $400.24 Million |
CN¥154.40 Million ≈ $22.59 Million |
0.056x | -36.36% |
| 2022-12-31 | CN¥2.82 Billion ≈ $412.05 Million |
CN¥249.77 Million ≈ $36.55 Million |
0.089x | +24.63% |
| 2021-12-31 | CN¥3.05 Billion ≈ $446.02 Million |
CN¥216.93 Million ≈ $31.74 Million |
0.071x | -42.48% |
| 2020-12-31 | CN¥3.26 Billion ≈ $477.47 Million |
CN¥403.73 Million ≈ $59.08 Million |
0.124x | -23.64% |
| 2019-12-31 | CN¥2.73 Billion ≈ $399.30 Million |
CN¥442.17 Million ≈ $64.70 Million |
0.162x | +91.21% |
| 2018-12-31 | CN¥2.41 Billion ≈ $352.18 Million |
CN¥203.95 Million ≈ $29.84 Million |
0.085x | +4151.69% |
| 2017-12-31 | CN¥2.09 Billion ≈ $305.86 Million |
CN¥-4.37 Million ≈ $-639.72K |
-0.002x | +90.26% |
| 2016-12-31 | CN¥2.05 Billion ≈ $300.66 Million |
CN¥-44.13 Million ≈ $-6.46 Million |
-0.021x | -156.14% |
| 2015-12-31 | CN¥1.42 Billion ≈ $207.15 Million |
CN¥54.16 Million ≈ $7.93 Million |
0.038x | +46.00% |
| 2014-12-31 | CN¥685.38 Million ≈ $100.29 Million |
CN¥17.96 Million ≈ $2.63 Million |
0.026x | -88.20% |
| 2013-12-31 | CN¥305.76 Million ≈ $44.74 Million |
CN¥67.91 Million ≈ $9.94 Million |
0.222x | -12.08% |
| 2012-12-31 | CN¥242.72 Million ≈ $35.52 Million |
CN¥61.32 Million ≈ $8.97 Million |
0.253x | -11.23% |
| 2011-12-31 | CN¥188.00 Million ≈ $27.51 Million |
CN¥53.50 Million ≈ $7.83 Million |
0.285x | +16.59% |
| 2010-12-31 | CN¥144.81 Million ≈ $21.19 Million |
CN¥35.35 Million ≈ $5.17 Million |
0.244x | +17.85% |
| 2009-12-31 | CN¥123.79 Million ≈ $18.11 Million |
CN¥25.64 Million ≈ $3.75 Million |
0.207x | +9.18% |
| 2007-12-31 | CN¥77.75 Million ≈ $11.38 Million |
CN¥14.75 Million ≈ $2.16 Million |
0.190x | -- |
About Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions.… Read more